Erbao Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Immunology top 5%
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
-
- Circular RNAs in diseases 4
-
- Cancer, Lipids, and Metabolism 5
- Cancer-related molecular mechanisms research 5
- Cancer Genomics and Diagnostics 2
- Co-authors
- Zheng‐Jun Zhou (10 shared papers)Zhi Dai (10 shared papers)Jian Zhou (10 shared papers)Jia Fan (8 shared papers)Shao‐Lai Zhou (8 shared papers)Zhiqiang Hu (2 shared papers)Xiaowu Huang (2 shared papers)Zheng Wang (2 shared papers)
- Journals
- BioMed Research International (2 papers)Annals of Translational Medicine (2 papers)Oncotarget (2 papers)Aging (2 papers)Cancer Management and Research (2 papers)
- Partner nations
- ChinaEthiopiaSaudi Arabia
In The Last Decade
Erbao Chen
34 papers receiving 1.4k citations
Erbao Chen's Hit Papers
Peers
Comparison fields: 5 of 77
- Cancer Research 316
- Immunology 416
- Oncology 436
- Hepatology 120
- Pulmonary and Respiratory Medicine 233
Countries citing papers authored by Erbao Chen
This map shows the geographic impact of Erbao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erbao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erbao Chen more than expected).
Fields of papers citing papers by Erbao Chen
This network shows the impact of papers produced by Erbao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erbao Chen. The network helps show where Erbao Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Erbao Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib Hit paper breakdown → | 2016 | 680 |
| 2 | 2019 | 100 | |
| 3 | 2019 | 87 | |
| 4 | 2015 | 66 | |
| 5 | 2016 | 37 | |
| 6 | 2018 | 33 | |
| 7 | 2022 | 31 | |
| 8 | 2019 | 29 | |
| 9 | 2022 | 26 | |
| 10 | 2019 | 25 | |
| 11 | 2023 | 24 | |
| 12 | 2020 | 22 | |
| 13 | 2018 | 21 | |
| 14 | 2018 | 21 | |
| 15 | 2019 | 16 | |
| 16 | 2017 | 16 | |
| 17 | 2023 | 16 | |
| 18 | 2019 | 15 | |
| 19 | 2019 | 13 | |
| 20 | 2020 | 13 |
About Erbao Chen
Erbao Chen is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 38 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Ferroptosis and cancer prognosis (5 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers), Testicular diseases and treatments (4 papers), Cancer Genomics and Diagnostics (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Cancer Research (316 citations), Immunology (416 citations), Oncology (436 citations), Hepatology (120 citations) and Pulmonary and Respiratory Medicine (233 citations). Erbao Chen has collaborated with scholars based in China, Ethiopia and Saudi Arabia. Frequent co-authors include Zheng‐Jun Zhou, Zhi Dai, Jian Zhou, Jia Fan, Shao‐Lai Zhou, Zhiqiang Hu, Xiaowu Huang, Zheng Wang, Ya Cao and Ke Peng. Their work appears in journals such as BioMed Research International, Annals of Translational Medicine, Oncotarget, Aging and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.